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Abstract
Background and Purpose—Although arteriopathies are the most common cause of childhood 
arterial ischemic stroke (AIS), and the strongest predictor of recurrent stroke, they are difficult to 
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diagnose. We studied the role of clinical data and follow-up imaging in diagnosing cerebral and 
cervical arteriopathy in children with AIS.
Methods—VIPS, an international prospective study, enrolled 355 cases of AIS (age 29d-18y) at 
39 centers. A neuroradiologist and stroke neurologist independently reviewed vascular imaging of 
the brain (mandatory for inclusion) and neck to establish a diagnosis of arteriopathy (definite, 
possible, or absent) in 3 steps: (1) baseline imaging alone; (2) plus clinical data; (3) plus follow-up 
imaging. A 4-person committee, including a second neuroradiologist and stroke neurologist, 
adjudicated disagreements. Using the final diagnosis as the gold standard, we calculated the 
sensitivity and specificity of each step.
Results—Cases were median 7.6 years of age (IQR 2.8, 14); 56% male. The majority (52%) 
were previously healthy; 41% had follow-up vascular imaging. Only 56 (16%) required 
adjudication. The gold standard diagnosis was definite arteriopathy in 127 (36%), possible in 34 
(9.6%), and absent in 194 (55%). Sensitivity was 79% at Step 1, 90% at Step 2, and 94% at Step 3; 
specificity was high throughout (99%, 100%, 100%), as was agreement between reviewers (Kappa 
0.77, 0.81, 0.78).
Conclusions—Clinical data and follow-up imaging help, yet uncertainty in the diagnosis of 
childhood arteriopathy remains. This presents a challenge to better understanding the mechanisms 
underlying these arteriopathies and designing strategies for prevention of childhood AIS.
Keywords
ischemic stroke; arteriopathy; vasculopathy; children; pediatric
Introduction
Stroke is among the top ten causes of death in childhood.1 Population-based estimates of the 
annual incidence of childhood stroke range from 4.6 to 13 per 100 000 children.2–4 
Traditional adult arterial ischemic stroke (AIS) risk factors such as hypertension, diabetes, 
smoking, and hypercholesterolemia are uncommon in children. Instead, pediatric AIS risk 
factors include arteriopathy, congenital heart disease, sickle cell disease, and hematologic 
abnormalities, among others.5–7 Childhood arteriopathies are increasingly recognized as a 
prevalent cause of childhood AIS, a strong predictor of recurrence and a predictor of poor 
short-term outcome.8–11 Prior estimates of the prevalence of arteriopathy range from 18% to 
64% of pediatric AIS cases.8, 12–15 This wide range likely reflects differences in imaging 
modalities, classification, and study populations, but primarily the fact that childhood 
arteriopathies are difficult to diagnose. Challenges to diagnosis include lack of standardized 
diagnostic criteria, technical limitations of imaging studies, reliance on MRA over 
conventional angiography, and heterogeneity of childhood arteriopathies.
In the prospective, international, NIH-funded “Vascular effects of Infection in Pediatric 
Stroke” (VIPS) study, we enrolled 355 cases of childhood AIS, and collected extensive 
clinical data and imaging studies for central review by study investigators. We sought to 
determine the role of clinical data, and baseline and follow-up imaging, in diagnosing the 
presence of a childhood arteriopathy.
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Material and Methods
Study Design
The VIPS study built on the existing infrastructure of the International Pediatric Stroke 
Study (IPSS).10 VIPS prospectively enrolled patients at 37 sites: 21 in the US, 6 in Canada, 
5 in Europe (UK, France Serbia), 3 in Asia (Philippines, China, Hong Kong), and 1 each in 
Australia and South America (Chile). Ethics committee approvals were obtained at all 
participating sites. Details of VIPS methods have been published.16 Criteria for site 
participation included MRI scanner with minimum magnet strength of 1.5 Tesla, MRI slice 
thickness of 5 mm or less, and ability to provide DICOM imaging data. With parents’ or 
guardians’ consent, sites enrolled pediatric patients aged 29 days through 18 years with AIS 
and collected extensive clinical histories, biological samples, and standardized brain and 
cerebrovascular imaging studies. All imaging was performed on a clinical basis. VIPS cases 
were initially confirmed by the local investigator using clinical and imaging diagnostic 
criteria for AIS: (1) a focal neurological deficit of acute onset or a seizure; and (2) a CT or 
MRI showing a focal brain infarct conforming to an established arterial territory in a 
location and of a maturity consistent with the neurological signs and symptoms. The clinical 
and imaging data were then subjected to a centralized review and case confirmation process, 
described below.
Brain and Vascular Imaging
All clinically obtained brain and vascular imaging were collected for central review. The 
minimum neuroimaging protocol for patient inclusion in VIPS consisted of the following 
brain MRI sequences: axial diffusion-weighted images (DWI), axial T2-weighted images, 
axial or coronal fluid-attenuated inversion recovery (FLAIR) images, and magnetic 
resonance angiography (MRA) of the brain. Conventional angiography and CT angiography 
(CTA) were also accepted in lieu of MRA. MRA of the neck was collected when performed. 
Participants were followed prospectively for a minimum of 1 year, and all follow-up 
imaging was collected during that time.
Case Confirmation
A study neuroradiologist (MW) and pediatric stroke neurologist (HJF) centrally reviewed 
baseline brain MRI scans and clinical data to confirm that each case met clinical and 
imaging criteria for AIS. Disagreements were resolved by a second neuroradiologist (AJB).
Initial Descriptive Imaging Review
Descriptive imaging review was performed centrally by two study neuroradiologists; 
disagreements were resolved by discussion including a third neuroradiologist. In their 
review of brain parenchymal imaging, the radiologists described infarct size (using ABC/
2),17 location, acuity, and associated hemorrhage. For the vascular imaging review (Figure 
1), the neuroradiologists initially classified the vascular imaging as normal or abnormal, and 
then completely described the vascular findings, including type of abnormality (hypoplasia, 
irregularity, banding, stenosis, intimal flap, mural hematoma, ectasia, fusiform aneurysm/
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pseudoaneurysm, and occlusion), vascular segments affected and degree of collateral flow. 
This was done for both baseline and all follow-up vascular imaging.
Arteriopathy Review and Classification
Images from VIPS patients showing vascular abnormalities during the initial vascular 
imaging review underwent a subsequent arteriopathy review process (Figure 1) that 
incorporated clinical data. A pediatric stroke neurologist (HJF) and neuroradiologist (MW) 
independently performed this review in three successive steps: Step 1, review of baseline 
imaging studies (and their centralized interpretation); Step 2, reevaluation with addition of 
clinical information; Step 3, reevaluation with addition of follow-up imaging when 
available.
At each step, the reviewers classified the “primary diagnosis”: no arteriopathy, possible 
arteriopathy or definite arteriopathy. Arteriopathy was defined as the imaging appearance of 
an in situ arterial abnormality (stenosis, irregularity, occlusion, banding, pseudoaneurysm, 
dissection flap) not attributable to an exogenous thrombus (e.g., cardioembolism) and not 
considered a normal developmental variant. Patients with an isolated arterial occlusion could 
be classified as having no arteriopathy (high certainty of occlusion due to thrombus), 
possible arteriopathy (etiology of occlusion unclear), or definite arteriopathy (high certainty 
of occlusion due to arteriopathy). We used features of both vascular and parenchymal 
imaging and clinical history (in Steps 2 and 3) to distinguish between an occlusion due to 
arteriopathy versus an occlusion due to thrombus. Features favoring thrombus (no 
arteriopathy) included: abrupt (as opposed to tapering) vessel occlusion, multiple arterial 
occlusions in a vascular tree (suggestive of an embolus that fragmented and resulted in 
multiple occlusions), multiple infarcts in a pattern suggestive of cardioembolism, clinical 
history suggesting high risk of cardioembolism (e.g., cardiac thrombus visualized on 
echocardiogram), and rapid resolution of occlusion on follow-up imaging. Features favoring 
arteriopathy included a pattern of vascular changes suggestive of moyamoya (distal internal 
carotid artery occlusion with lenticulostriate collaterals), clinical history of a disorder 
associated with moyamoya (e.g., sickle cell disease, trisomy 21), and changes suggestive of 
dissection (e.g., dissection flap or tapering occlusion), especially with a history of severe 
head or neck injury. If cause of the occlusion was unclear, the reviewers classified these as 
“possible arteriopathy.”
At each step, for patients with possible and definite arteriopathy, the reviewers also 
attempted to establish a “secondary diagnosis” by classifying the arteriopathies into 
subtypes: arterial dissection, transient cerebral arteriopathy (TCA), primary and secondary 
moyamoya, genetic or syndromic arteriopathies such as PHACE syndrome,18, 19 primary 
and secondary vasculitis, fibromuscular dysplasia, iatrogenic, and others. If a single 
diagnosis could not be made with high certainty, they created a differential diagnosis. The 
reviewers used pre-established definitions for childhood arteriopathies.20 TCA referred very 
specifically to a focal cerebral arteriopathy involving the distal internal carotid artery and/or 
its proximal branches, presumed inflammatory, with a stereotyped, monophasic natural 
history characterized by frequent early progression (over days to weeks), plateau with 
nonprogression by 6 months, and subsequent improvement in some with complete resolution 
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in a minority.20, 21 Focal cerebral arteriopathy of childhood (FCA) is a broader label coined 
to describe intracranial anterior circulation pathology in children at the time of AIS, when 
TCA may be suspected but cannot be diagnosed with certainty due to lack of follow-up 
imaging.9 FCA has its own differential diagnosis (including TCA and intracranial 
dissection); hence, we did not include it as an option for secondary diagnosis.
At any step, if the reviewers disagreed on the primary diagnosis, or had no overlap in their 
differentials for the secondary diagnosis, the cases were adjudicated by a four-person 
committee, including a second neuroradiologist (AJB) and a second pediatric neurologist 
(GDV). The adjudication became the “gold standard” for those cases. If no disagreement, 
the gold standard was the Step 3 interpretation when follow-up imaging was available, and 
the Step 2 interpretation when no follow-up imaging was available.
Statistical Analysis
Characteristics were compared across the three arteriopathy groups (definite, possible, and 
none) using the non-parametric Kruskal-Wallis test for continuous variables, and the chi-
square test for categorical variables. When the latter contained cells of fewer than five 
observations, p-values were calculated using Fisher’s exact test. For each of the three 
arteriopathy review steps, we calculated the sensitivity, specificity, positive predictive value 
and negative predictive value of that step’s primary diagnosis (definite arteriopathy as a 
binary variable) using the gold standard primary diagnosis described above. Individual 
reviewer diagnoses at each step were also compared to each other in order to assess reviewer 
agreement (independent of “gold standard” diagnosis). Interobserver agreement at each of 
the three steps was represented utilizing simple Kappa statistics and their confidence 
intervals. All analyses were done using Stata v12 (Stata Corp., College Station, TX).
Results
Between 1/2010 and 3/2014, VIPS prospectively enrolled 387 pediatric patients. Of these, 
355 (92%) were centrally confirmed as meeting study criteria for AIS. Demographics, 
presentation, and co-morbidities are shown in Table 1; 184 (52%) were previously healthy 
(no chronic or acute illness prior to their stroke diagnosis).
Arteriopathy Review
In 116 (32.7%) patients, there were no abnormalities on the initial vascular imaging review, 
and the arteriopathy review was not performed (Figure 1). The other 239 underwent 
arteriopathy review; full committee adjudication was performed in 56 cases (23% of 239). 
The source of the gold standard arteriopathy diagnosis is shown in Table 2. Overall, 127 
patients (36%) received a gold standard diagnosis of definite arteriopathy, 34 (9.6%) 
possible arteriopathy, and 194 (55%) no arteriopathy (Table 2). Of the 184 previously 
healthy children, 42% had a definite arteriopathy, 13% possible arteriopathy, and 45% no 
arteriopathy, compared to 29%, 6%, and 65%, respectively, for the 171 non-healthy children 
(p=0.0005). Of the 127 with definite arteriopathy, 109 (86%) received a single secondary 
diagnosis, while 18 (14%) could not be further classified with certainty. Demographics were 
similar amongst patients with no, possible and definite arteriopathy, although the Filipino 
Wintermark et al. Page 5
Stroke. Author manuscript; available in PMC 2015 December 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
site had a high proportion of cases with definite arteriopathy related to cases of secondary 
vasculitis due to tuberculosis meningitis (Supplemental Table I).
Interobserver agreement on the primary diagnosis yielded a Kappa of 0.77 (95% CI, 0.70, 
0.84) at Step 1. Sensitivity of the Step 1 primary diagnosis (for the gold standard primary 
diagnosis) was 79%, and specificity was 99%. The positive predictive value (PPV) of the 
Step 1 primary diagnosis was 97%, and the negative predictive value (NPV) was 89%. 
When clinical data were added (Step 2), interobserver agreement yielded a Kappa 
coefficient of 0.81 (95% CI, 0.74, 0.87) and sensitivity and specificity increased to 90% and 
100%, respectively. PPV rose to 100% and NPV to 95%. In the 110 patients with follow-up 
imaging (Step 3), the Kappa coefficient for interobserver agreement was 0.78 (95% CI 0.66, 
0.90). Sensitivity for the Step 3 primary diagnosis rose to 94%, with a specificity of 100%. 
PPV remained at 100%, while NPV dropped slightly to 91%.
Imaging Work-Up and Infarct Characteristics
The imaging studies performed were similar across children stratified by primary 
arteriopathy diagnosis, except that those with no arteriopathy were less likely to have 
conventional angiograms and follow-up vascular imaging (Supplemental Table II). Infarcts 
in the territory of the middle cerebral artery were the most common location in each stratum. 
Infarct volume was greatest in those with definite arteriopathy (p=0.009; Table 3).
Vascular Imaging Findings
Arterial banding, intimal flap, and intramural hematoma were seen exclusively in patients 
with definite arteriopathy as these imaging features were used to diagnose arteriopathy 
(Table 3). One child in the “no arteriopathy” group had a mycotic aneurysm: because the 
stroke was due to underlying endocarditis, and unrelated to the aneurysm, it was considered 
cardioembolic. Vascular irregularity and stenosis were observed more often in patients with 
arteriopathy, but were also seen in patients without arteriopathy and attributed to 
recanalizing thrombus (such as from cardioembolism). Occlusion was a nonspecific finding 
that was observed frequently in all subgroups, but most commonly in the possible 
arteriopathy subgroup, reflecting uncertainty regarding whether the occlusion was due to 
arterial disease or embolism. When more than one arterial segment was affected, or infarcts 
were present in more than one vascular territory, definite arteriopathy was more likely. The 
diagnosis of definite arteriopathy was associated with a higher proportion of vascular 
imaging findings progressing over time, or progressing then improving.
Discussion
In a large prospective, multicenter, international study, we found that arteriopathy is a 
common cause of childhood AIS, present in up to 45% of cases (including those with a 
“possible” arteriopathy). More than half the cases were previously healthy children at the 
time of their stroke; among them, arteriopathy was present in up to 58%. In our stepwise 
review process, reviewer agreement was high at each step, and clinical data and follow-up 
imaging increased the sensitivity for the final “gold standard” primary diagnosis of definite 
arteriopathy. However, 10% of all cases could not be definitively classified as having, or not 
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having, arteriopathy—suggesting that even with central review by a panel of pediatric stroke 
investigators, considerable uncertainty remains around childhood arteriopathy diagnosis.
Arteriopathies are important because they are not only a prevalent cause of childhood AIS, 
but the strongest predictor of recurrence. In 667 cases enrolled at 30 sites in the IPSS (2003–
2007), 53% were classified as having an arteriopathy by the site investigators.9 In a 
population-based study of Californian children enrolled in a managed care plan (1993–
2004), 52 children had vascular imaging after AIS: 22 (42%) had non-occlusive 
abnormalities of cerebral or cervical arteries and another 6 (12%) had large-vessel 
occlusion.8 While there were no recurrences among 24 children with normal vascular 
imaging, the 5-year cumulative recurrence rate among those with abnormalities was 66% 
(p<0.001). A prospective German study of 301 childhood AIS cases (1995–2000) similarly 
found that arteriopathy was the strongest predictor of recurrence (OR 3.9, 95% CI 1.4, 
10.6).13 Hence, accurate diagnosis of childhood arteriopathy is important both for 
understanding an individual child’s risk of recurrent stroke and for the design of secondary 
stroke prevention trials.
The results of VIPS also demonstrate that childhood arteriopathies remain difficult to 
diagnose. Standard vascular imaging is currently limited to “lumenology”—imaging of the 
arterial lumen, and not the wall of the artery—making it difficult to distinguish a diseased 
artery from thrombus in a vessel. Imaging features that were particularly suggestive of 
definite arteriopathy included arterial banding, intimal flap, intramural hematoma, ectasia/
aneurysm, and pseudoaneurysm. Vascular irregularity and stenosis were less specific. 
Occlusion was nonspecific, common in all groups, and most common in the “possible 
arteriopathy” group, reflecting uncertainty as to whether the artery was diseased, or 
occluded by thrombus. In VIPS, we observed cases with arterial stenosis on baseline 
imaging highly suggestive of arteriopathy, yet a clinical history of cardiac thrombus 
suggested partially recanalized thrombus (Figure 2). The addition of clinical data increased 
the sensitivity of the primary diagnosis of arteriopathy (from 79% to 90%), but must be 
applied with caution as cardiac disease can be coincident with arteriopathy in childhood: 
Down syndrome, for example, is associated with congenital heart defects, moyamoya 
syndrome, and arterial dissection due to cervical instability.22–24 Follow-up vascular 
imaging was important, increasing the sensitivity to 94%. Rapid resolution of stenosis 
pointed towards a resolving thrombus, while a persistent, or even progressive, stenosis 
suggested arteriopathy. However, rapid diagnosis of arteriopathy is important if we hope to 
develop interventions to prevent recurrent stroke in children, most of which occur days to 
weeks after first AIS.8, 13, 25 Improved imaging techniques are needed. Arterial wall 
imaging, which allows the detection of blood products and enhancement in the vessel walls, 
may prove to be of benefit to children with AIS by allowing early arteriopathy 
diagnosis.26, 27
Another challenge is that childhood AIS is uncommon, so it is difficult for neuroradiologists 
and neurologists to gain experience in diagnosing childhood arteriopathies. Some 
arteriopathies are unique to childhood, and only rarely seen in adults with stroke. This 
includes TCA, a common arteriopathy among previously healthy children; the proximal 
middle cerebral artery banding seen in the very acute phase of this disease can be confused 
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with fibromuscular dysplasia (FMD), an arteriopathy with a very different natural history 
(Figure 3).28 Adding further to the challenge, the arteriopathies that are more common in 
adults are rarely seen in children. We made no diagnoses of atherosclerosis in VIPS, even 
among adolescents, and also no diagnoses of primary CNS vasculitis. Lastly, the 
arteriopathies observed in children vary somewhat by geographic location: of 15 cases of 
secondary vasculitis in VIPS, 7 were enrolled in the Philippines, where tuberculosis 
meningitis remains a common cause of childhood AIS.
Lack of a reliable and user-friendly classification system for childhood arteriopathies 
remains another challenge. Definitions for childhood arteriopathies have been published,20 
and were used in our study, but can be difficult to apply for all the reasons mentioned above. 
The best available system is the “Childhood AIS Standardized Classification and Diagnostic 
Evaluation” (CASCADE) system for classification of childhood AIS etiology, including 
arteriopathies.29 This system has taken a descriptive approach to arteriopathies (including 
categories such as “unilateral focal cerebral arteriopathy of childhood” and “bilateral 
cerebral arteriopathy of childhood”), and achieved good inter-rater reliability. But further 
work is needed to link these categories to both underlying mechanisms and prognosis, 
particularly recurrence risk.
The main limitation of our study was the variability in patient evaluation related to our 
complete reliance on clinically-obtained studies. Research imaging studies would have been 
prohibitively costly, and would have presented ethical issues related to the need for 
anesthesia in younger children. Although most baseline vascular imaging studies were 
MRAs of good quality, their timing with respect to the stroke ictus was variable. Only half 
of cases had cervical imaging, and only 14% had conventional angiography, which still is 
the gold standard for vascular imaging. The timing and frequency of follow-up vascular 
imaging was also variable, and many patients with normal vascular imaging at baseline did 
not receive follow-up, precluding an assessment of whether early MRA can be insensitive to 
acute arteriopathies like TCA. (In one VIPS case of TCA, the baseline MRA had been 
clinically interpreted as normal, then progressed to severe middle cerebral artery stenosis 
within days.) However, the VIPS study is the first-ever international study of childhood AIS 
to perform centralized imaging review, which allowed us to consistently apply methods for 
diagnosis of childhood arteriopathy.
Conclusions
Arteriopathy is common among children with AIS, particularly previously healthy children, 
but remains difficult to diagnose. Clinical data and follow-up imaging both aid in the 
diagnosis. More systematic use of follow-up vascular imaging, and advances in techniques 
such as arterial wall imaging, may prove helpful, and could assist both with prognostication 
in an individual child, and selection of children for secondary stroke prevention trials. We 
plan to perform further work with the VIPS cohort to determine predictors of arteriopathy 
subtypes, with the aim of developing simple algorithms that may assist a clinical 
neuroradiologist or neurologist in generating a reasonable differential diagnosis for 
arteriopathy in a child with AIS.
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Figure 1. 
Flow diagram demonstrating how 355 children with arterial ischemic stroke (AIS) received 
a primary diagnosis of definite, possible, or no arteriopathy.
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Figure 2. 
Child with a left middle cerebral infarct (a, axial DWI, arrow), whose baseline MRA 
showed distal left internal carotid artery (ICA) stenosis (b, arrows), classified as a “definite 
arteriopathy” on baseline imaging review without clinical data. Clinical data revealed 
congenital heart disease with a intracardiac thrombus, suggesting the stenosis was due to 
embolus. Follow-up MRA 3 months later revealed complete occlusion of the ICA (c, 
arrows). The child’s final classification was “no arteriopathy,” cardioembolic etiology.
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Figure 3. 
Angiographic injection of the internal carotid artery showing banding (and small 
pseudoaneurysm) of the proximal middle cerebral artery (arrow) in a case of “transient 
cerebral arteriopathy” (TCA), a presumed inflammatory monophasic focal arteriopathy of 
the distal internal carotid artery and its proximal branches.
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Table 1
Demographics and clinical characteristics of 355 childhood arterial ischemic stroke cases
n (%)
Demographics
  Age in years, median (IQR) 7.6 (2.8, 14.3)
  Male gender 199 (56.1)
  Race
    White 230 (64.8)
    Black 39 (11.0)
    Indian/South Asian 26 (7.3)
    East Asian 9 (2.5)
    First Nations/Aboriginal 4 (1.1)
    Middle Eastern 3 (0.8)
    Pacific Islander 1 (0.3)
    Mixed or other 38 (10.7)
    Unknown 5 (1.4)
  Ethnicity
    Non-Hispanic 289 (81.4)
    Hispanic 47 (13.2)
    Mixed or other 19 (5.4)
  Country
    USA 223 (62.8)
    Canada 60 (16.9)
    Australia 16 (4.5)
    Philippines 16 (4.5)
    Chile 14 (3.9)
    United Kingdom 11 (3.1)
    France 6 (1.7)
    Serbia 5 (1.4)
    China 4 (1.1)
Stroke presentation
  Focal signs
    Hemiparesis 285 (80.3)
    Dysarthria 97 (27.3)
    Aphasia 79 (22.3)
    Ataxia 71 (20.0)
    Visual field deficit 46 (13.0)
  Non-focal signs
    Headache 126 (35.5)
    Decreased level of consciousness 102 (28.7)
    Nausea/vomiting 85 (23.9)
    Seizures at presentation 84 (23.7)
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n (%)
    Vertigo 40 (11.3)
    Diplopia 12 (3.4)
    Papilledema 4 (1.1)
Risk factors or co-morbidities (not mutually exclusive)
  Cardiac disease 107 (30.1)
    Congenital heart disease 64 (18.0)
    Acquired heart disease 21 (5.9)
    Isolated patent foramen ovale 21 (5.9)
    Stroke at cardiac surgery (<72 hours) 10 (2.8)
    Other cardiac disease 41 (11.5)
  Other chronic disorders
    Sickle cell anemia 13 (3.7)
    Downs syndrome 11 (3.1)
    Other genetic syndrome 16 (4.5)
    Migraine 12 (3.4)
    Prothrombotic state 10 (2.8)
    Oral contraceptives (females only) 10 (6.4)
    Indwelling catheter 9 (2.5)
    Iron deficiency anemia 6 (1.7)
    Brain tumor 5 (1.4)
      Benign 2 (0.6)
      Malignant 3 (0.8)
    Aneurysm 3 (0.8)
    PHACES syndrome/hemangioma 3 (0.8)
    Hematologic malignancy 2 (0.6)
    L-asparaginase therapy 2 (0.6)
    Connective tissue disease 2 (0.6)
    Ventriculoperitoneal shunt 1 (0.3)
  Acute systemic illness
    Fever lasting >48 hours 44 (12.4)
    Systemic sepsis or bacteremia 20 (5.6)
    Dehydration 18 (5.1)
    Shock 9 (2.5)
    Viral gastroenteritis 2 (0.6)
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Table 2
"Gold standard" arteriopathy diagnosis in 355 childhood arterial ischemic stroke cases
n (%)
Source of "gold standard" arteriopathy classification
  Vascular imaging review (normal, no arteriopathy review) 116 (32.7)
  Arteriopathy diagnosis review 239 (67.3)
    Baseline with clinical findings (Step 2) 94 (26.5)
    Follow-up (Step 3) 89 (25.1)
    Adjudication 56 (15.8)
Definite arteriopathy 127 (35.8)
  Secondary diagnosis classified with high certainty* 109 (30.7)
    Arterial dissection 26 (7.3)
    Transient cerebral arteriopathy 25 (7.0)
    Primary moyamoya 17 (4.8)
    Secondary moyamoya 17 (4.8)
    PHACES 2 (0.6)
    Genetic arteriopathy 4 (1.1)
    Primary vasculitis 0 (0)
    Secondary vasculitis (including meningitis) 15 (4.2)
    Iatrogenic 1 (0.3)
    Fibromuscular dysplasia 2 (0.6)
  Secondary diagnosis not further classified 18 (5.1)
    Differential diagnosis includes:**
Transient cerebral arteriopathy 9 (2.5)
Arterial dissection 11 (3.1)
Primary moyamoya 4 (1.1)
Secondary moyamoya 0 (0)
Genetic arteriopathy 1 (0.3)
Primary vasculitis 2 (0.6)
Secondary vasculitis (including meningitis) 4 (1.1)
Iatrogenic 0 (0)
Possible arteriopathy 34 (9.6)
    Differential diagnosis includes:**
Transient cerebral arteriopathy 9 (2.5)
Arterial dissection 27 (7.6)
Primary moyamoya 1 (0.3)
Secondary moyamoya 0 (0)
Genetic arteriopathy 0 (0)
Primary vasculitis 1 (0.3)
Secondary vasculitis (including meningitis) 7 (2.0)
Iatrogenic 0 (0)
Embolic (not arteriopathy) 33 (9.3)
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n (%)
No arteriopathy 194 (54.6)
  No abnormalities on vascular imaging (no arteriopathy review) 116 (32.7)
  Arteriopathy review 78 (22.0)
    Classified as no arteriopathy, no embolus 1 (0.3)
    Classified as no arteriopathy, low likelihood embolic 2 (0.6)
    Classified as isolated occlusion, high likelihood embolic 75 (21.1)
*Sub-categories are mutually exclusive
**Sub-categories are not mutually exclusive
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